Latest news with #Synthomer
Yahoo
7 days ago
- Business
- Yahoo
Analysts Have Been Trimming Their Synthomer plc (LON:SYNT) Price Target After Its Latest Report
Shareholders in Synthomer plc (LON:SYNT) had a terrible week, as shares crashed 23% to UK£0.62 in the week since its latest half-year results. Revenues were UK£925m, with Synthomer reporting some 6.8% below analyst expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Following last week's earnings report, Synthomer's six analysts are forecasting 2025 revenues to be UK£1.86b, approximately in line with the last 12 months. Losses are predicted to fall substantially, shrinking 33% to UK£0.31. Before this latest report, the consensus had been expecting revenues of UK£1.96b and UK£0.24 per share in losses. So it's pretty clear the analysts have mixed opinions on Synthomer after this update; revenues were downgraded and per-share losses expected to increase. Check out our latest analysis for Synthomer The consensus price target fell 6.7% to UK£1.57, with the analysts clearly concerned about the company following the weaker revenue and earnings outlook. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Synthomer analyst has a price target of UK£3.66 per share, while the most pessimistic values it at UK£0.70. With such a wide range in price targets, analysts are almost certainly betting on widely divergent outcomes in the underlying business. With this in mind, we wouldn't rely too heavily the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business. These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Synthomer's past performance and to peers in the same industry. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 2.6% by the end of 2025. This indicates a significant reduction from annual growth of 2.0% over the last five years. Yet aggregate analyst estimates for other companies in the industry suggest that industry revenues are forecast to decline 16% per year. The forecasts do look comparatively optimistic for Synthomer, since they're expecting it to shrink slower than the industry. The Bottom Line The most important thing to note is the forecast of increased losses next year, suggesting all may not be well at Synthomer. Unfortunately, they also downgraded their revenue estimates, and our data indicates that is expected to perform better than the wider industry. Even so, earnings per share are more important to the intrinsic value of the business. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of Synthomer's future valuation. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Synthomer going out to 2027, and you can see them free on our platform here. It is also worth noting that we have found 2 warning signs for Synthomer (1 shouldn't be ignored!) that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-08-2025
- Business
- Yahoo
Synthomer First Half 2025 Earnings: UK£0.22 loss per share (vs UK£0.18 loss in 1H 2024)
Explore Synthomer's Fair Values from the Community and select yours Synthomer (LON:SYNT) First Half 2025 Results Key Financial Results Revenue: UK£925.2m (down 9.8% from 1H 2024). Net loss: UK£35.9m (loss widened by 20% from 1H 2024). UK£0.22 loss per share (further deteriorated from UK£0.18 loss in 1H 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Synthomer Earnings Insights Looking ahead, revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Performance of the British Chemicals industry. The company's shares are down 21% from a week ago. Risk Analysis You should learn about the 2 warning signs we've spotted with Synthomer (including 1 which shouldn't be ignored). Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
27-06-2025
- Business
- Associated Press
Henkel and Synthomer Partner To Cut Carbon Emissions in Adhesives
DÜSSELDORF /3BL/ - Henkel, a global leader in adhesives, sealants and functional coatings, and Synthomer, a world-leading supplier of high-performance, highly-specialized polymers and ingredients, have announced a strategic partnership and supply agreement focused on enabling carbon emission reductions in Henkel's TECHNOMELT® hot melt adhesive product portfolio for the European, Indian, Middle Eastern and African markets. This collaboration highlights both companies' leadership in advancing sustainable adhesives through innovative collaborations along the value chain. This partnership follows Synthomer's recent launch of CLIMA-branded products. Products with this designation, like their REGALITETM line, deliver at least a 20% reduction cradle-to-gate in the product carbon footprint by using renewable energy in the production process. Henkel and Synthomer have jointly developed a framework that links renewable energy use directly to specific adhesive products, enabling measurable reductions in carbon emissions. Henkel and Synthomer's partnership is built on a mutual commitment to sustainability. Henkel aims to reduce absolute Scope 3 GHG emissions by 30 percent by 2030 (base year 2021), with the goal of becoming net-zero by 2045. To support this, it is incorporating raw materials with reduced process emissions footprint into adhesive formulations, helping lower Scope 3 emissions while maintaining high quality performance. Synthomer is contributing by reducing emissions from manufacturing operations, with a goal to cut absolute Scope 1 and 2 greenhouse gas emissions 47 percent by 2030, using 2019 as the base year in line with its Science-Based Targets goals. Synthomer's improved manufacturing approach leverages renewable electricity, biogas and process optimization, significantly lowering the carbon footprint of their products. These carbon reductions are measured through Product Carbon Footprint (PCF) reporting, which follows ISO14067 standards and the Together for Sustainability (TfS) guidelines. The PCF methodology used in this collaboration is being externally validated by TÜV SÜD, adding a strong layer of verification and credibility. 'As industry leaders in the adhesives market, we share the responsibility to drive meaningful change,' said Pernille Lind Olsen, Corporate Senior Vice President, Adhesive Technologies Henkel. 'By partnering with suppliers like Synthomer who are equally committed to transparency, innovation, and verifiable climate action, we're not just reducing emissions, we're redefining what leadership looks like in our industry.' 'We are proud to support Henkel and their customers with novel adhesive solutions based on a significantly reduced carbon footprint. Our capability is based on our broad portfolio of high performing adhesive ingredients, a global production and development network paired with a relentless passion for innovation and sustainability. We continue to engage with partners to create sustainable value chains and reduce carbon emissions on our planet.' says Stephan Lynen, Synthomer's President for Adhesive Solutions. Hot melt adhesives are used in a variety of industries and applications from packaging and consumer goods to electronics and automotive. The integration of Synthomer's CLIMA resins into Henkel's TECHNOMELT® hot melt adhesive portfolio will lower environmental impact while maintaining the same high-quality solutions the market expects from Henkel. TECHNOMELT® adhesives are trusted for reliability, quality and proven results across a variety of applications. The shared focus on sustainable product development and carbon footprint transparency highlights how strategic partnerships can drive progress and establish industry standards. About Synthomer plcSynthomer plc is a leading supplier of high-performance, highly specialized polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed there since 1971, we employ c.4,000 employees across our five innovation centers of excellence and 31 manufacturing sites across Europe, North America, Middle East and purpose is creating innovative and sustainable solutions for the benefit of customers and society. Around 20% of our sales volumes are from new and patent protected products. At our innovation centers of excellence in the UK, China, Germany, Malaysia and USA we collaborate closely with our customers to develop new products and enhance existing ones tailored to their needs, with an increasing range of sustainability benefits. Our 2030 decarbonization targets have been approved by the Science Based Targets initiative as being in line with what the latest climate science says is necessary to meet the goals of the Paris Agreement, and since 2021 we have held the London Stock Exchange Green Economy Mark, which recognizes green technology businesses making a significant contribution to a more sustainable, low-carbon economy. Find us at or search for Synthomer on LinkedIn. Contact:Sebastian HinzAdhesive TechnologiesMedia RelationsHeadquarters, Düsseldorf/[email protected] Visit 3BL Media to see more multimedia and stories from Henkel
Yahoo
12-03-2025
- Business
- Yahoo
Synthomer Full Year 2024 Earnings: EPS Misses Expectations
Revenue: UK£1.99b (flat on FY 2023). Net loss: UK£70.0m (loss narrowed by 32% from FY 2023). UK£0.43 loss per share (improved from UK£1.20 loss in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.0% decline forecast for the Chemicals industry in the United Kingdom. Performance of the British Chemicals industry. The company's shares are up 12% from a week ago. We should say that we've discovered 2 warning signs for Synthomer (1 shouldn't be ignored!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
12-03-2025
- Business
- Yahoo
Synthomer Full Year 2024 Earnings: EPS Misses Expectations
Revenue: UK£1.99b (flat on FY 2023). Net loss: UK£70.0m (loss narrowed by 32% from FY 2023). UK£0.43 loss per share (improved from UK£1.20 loss in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.0% decline forecast for the Chemicals industry in the United Kingdom. Performance of the British Chemicals industry. The company's shares are up 12% from a week ago. We should say that we've discovered 2 warning signs for Synthomer (1 shouldn't be ignored!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
